Vůle podložka Převzít events per 100 patient years Hrubý spánek Blesk Kalamita
Adverse Events Incidence Rates
Event rates per 100 patient-years follow-up (number of events) | Download Table
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure | SpringerLink
Cleveland Clinic Journal of Medicine : March 2023 - CD
Event rate (per 100 patient-years) and risk of study endpoints... | Download Scientific Diagram
Adverse events of special interest per 100 patient-years during the... | Download Scientific Diagram
Event rates per 100 patient-years at 3 years for important vascular... | Download Scientific Diagram
Event rate per 100 patient-years of adverse clinical events for each... | Download Scientific Diagram
ncidence of severe hypoglycemic episodes per 100 patient-years in... | Download Scientific Diagram
Cleveland Clinic Journal of Medicine : September 2021 - CD
Treatment-emergent adverse events per 100 patient-years by years of... | Download Scientific Diagram
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis | NEJM
RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
Integrated Laboratory Abnormality Profiles of Upadacitinib with up to 4.5 Years of Exposure in Patients with Rheumatoid Arthritis Treated in a Phase 3 Clinical Trial - ACR Meeting Abstracts
Adverse events of special interest per 100 patient-years during the... | Download Scientific Diagram
Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events | Circulation: Cardiovascular Interventions
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment | The Journal of Rheumatology
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE
Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo. - ppt download
Incidence of serious adverse events per 100 patient-years in the UPLIFT... | Download Table
Adalimumab trials show low rate of IBD adverse events
Dupilumab reduces length, frequency of hospital stays for patients with atopic dermatitis
Adverse events per 100 patient-years of exposure | Download Scientific Diagram
exposure-adjusted Aes through week 52 (event rate per 100 patient-years) | Download Table
incidence rate (events/100 patient-years) of AE and ADR classifi ed by... | Download Scientific Diagram
Patient Years Multiplier:
Tezepelumab shows long-term safety, efficacy for severe asthma